Retatrutide 40MG
· Lyophilised powder
Triple GIP/GLP-1/glucagon receptor agonist Retatrutide, 30 mg lyophilised vial.
RETATRUTIDE 40MG is a premium lyophilized peptide intended for laboratory and scientific research use only. Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors, making it a significant area of study in metabolic and obesity research. It is being investigated for its potential effects on body weight regulation, glucose metabolism, appetite control, and energy expenditure.
Product Features
- Strength: 40 mg per vial
- Form: Lyophilized (freeze-dried) powder
- High purity and quality
- Manufactured under strict quality control standards
- Securely sealed sterile vial
-
Research Applications
Retatrutide is currently being studied in preclinical and clinical research involving:
- Metabolic regulation
- Obesity and weight management
- Glucose homeostasis
- Energy expenditure
- Appetite signaling
- Compound
- Retatrutide 40MG
- Strength
- Form supplied
- Lyophilised powder
- Research areas
- Metabolic/GLP-1
- Storage
- Store lyophilised material refrigerated between 2–8°C (Celsius), cold and dark, protected from light and moisture.
- Batch reference
- Stated on the vial label at dispatch
- Analytical documentation
- No analytical document is currently held for this batch. Where documentation is held it is published here.
Specification
Research-use notice
All products supplied by The Peptide Kings are sold strictly for laboratory research use only. They are not medicines, not dietary supplements, and are not intended for human or veterinary consumption or administration. Information published on this website is provided for educational and scientific reference purposes only and must not be interpreted as medical advice.